Cellectar Biosciences Inc (CLRB)
0.2522
-0.02
(-8.52%)
USD |
NASDAQ |
Dec 24, 12:10
Cellectar Biosciences Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -340.80M |
| Ligand Pharmaceuticals Inc | -46.51M |
| Revance Therapeutics Inc | 23.29M |
| Zymeworks Inc | 72.26M |
| Applied Therapeutics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.167M |
| Cash from Financing (Quarterly) | 17.56M |
| Free Cash Flow | -46.57M |
| Free Cash Flow Per Share (Quarterly) | -0.2304 |
| Free Cash Flow Yield | -607.3% |